Institutional Ownership Vera Therapeutics, Inc. (VERA)
This table provides information about the institutional ownership of Vera Therapeutics, Inc. (VERA). We have compiled data on the 196 institutions that hold shares in the stock, with a total of 63.9 Million shares, which have been reported (via 13F filing form) to have a value of $1.36 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Voya Investment Management LLC
Atlanta, GA |
May 15, 2025 Q1 2025 |
627,357
shares
|
$13.1 Million
0.02% of portfolio
|
Q1 2025
Reduced 9.74%
|
|
|
First Turn Management, LLC
Del Mar, CA |
May 15, 2025 Q1 2025 |
623,612
shares
|
$13 Million
3.02% of portfolio
|
Q1 2025
Added 34.17%
|
|
|
Rock Springs Capital Management LP
Baltimore, MD |
May 15, 2025 Q1 2025 |
520,796
shares
|
$10.9 Million
0.75% of portfolio
|
Q1 2025
Added 6.75%
|
|
|
Jennison Associates LLC
|
May 02, 2025 Q1 2025 |
507,838
shares
|
$10.6 Million
0.01% of portfolio
|
Q1 2025
Reduced 37.6%
|
|
|
Goldman Sachs Group Inc
New York, NY |
May 16, 2025 Q1 2025 |
505,918
shares
|
$10.6 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.8%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
May 15, 2025 Q1 2025 |
481,065
shares
|
$10.1 Million
0.36% of portfolio
|
Q1 2025
Reduced 35.22%
|
|
|
Ubs Group Ag
|
May 13, 2025 Q1 2025 |
459,667
shares
|
$9.61 Million
0.0% of portfolio
|
Q1 2025
Added 372.41%
|
|
|
Schroder Investment Management Group
London, X0 |
May 13, 2025 Q1 2025 |
458,841
shares
|
$9.59 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.42%
|
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
440,689
shares
|
$9.21 Million
0.0% of portfolio
|
Q1 2025
Added 34.15%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
424,940
shares
|
$8.89 Million
0.0% of portfolio
|
Q1 2025
Reduced 1.33%
|
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
418,259
shares
|
$8.75 Million
0.0% of portfolio
|
Q1 2025
Reduced 8.08%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2025 Q1 2025 |
415,719
shares
|
$8.69 Million
1.85% of portfolio
|
Q1 2025
Added 61.26%
|
|
|
American Century Companies Inc
Kansas City, MO |
May 13, 2025 Q1 2025 |
377,450
shares
|
$7.89 Million
0.01% of portfolio
|
Q1 2025
Reduced 12.0%
|
|
|
Candriam S.C.A.
|
May 14, 2025 Q1 2025 |
363,692
shares
|
$7.6 Million
0.06% of portfolio
|
Q1 2025
Reduced 0.63%
|
|
|
Affinity Asset Advisors, LLC
New York, NY |
May 14, 2025 Q1 2025 |
355,143
shares
|
$7.43 Million
0.95% of portfolio
|
Q1 2025
Reduced 16.44%
|
|
|
Qube Research & Technologies LTD
London, X0 |
May 15, 2025 Q1 2025 |
344,623
shares
|
$7.21 Million
0.01% of portfolio
|
Q1 2025
Added 102.14%
|
|
|
Armistice Capital, LLC
New York, NY |
May 15, 2025 Q1 2025 |
300,000
shares
|
$6.27 Million
0.11% of portfolio
|
Q1 2025
Added 68.27%
|
|
|
Gw&K Investment Management, LLC
Boston, MA |
May 05, 2025 Q1 2025 |
252,240
shares
|
$5.27 Million
0.06% of portfolio
|
Q1 2025
Added 35.17%
|
|
|
Td Asset Management Inc
|
May 07, 2025 Q1 2025 |
252,164
shares
|
$5.27 Million
0.01% of portfolio
|
Q1 2025
Added 9.37%
|
|
|
Axa S.A.
Paris, I0 |
May 15, 2025 Q1 2025 |
245,565
shares
|
$5.13 Million
0.02% of portfolio
|
Q1 2025
Reduced 0.13%
|
|
|
Alphabet Inc.
Mountain View, CA |
May 01, 2025 Q1 2025 |
241,264
shares
|
$5.04 Million
0.52% of portfolio
|
Q1 2024
Reduced 20.0%
|
|
|
Bank Of America Corp
Charlotte, NC |
May 15, 2025 Q1 2025 |
227,016
shares
|
$4.75 Million
0.0% of portfolio
|
Q1 2025
Added 650.61%
|
|
|
Victory Capital Management Inc
|
May 02, 2025 Q1 2025 |
221,740
shares
|
$4.64 Million
0.01% of portfolio
|
Q1 2025
Reduced 5.75%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2025 Q1 2025 |
211,795
shares
|
$4.43 Million
0.0% of portfolio
|
Q1 2025
Added 286.44%
|
|
|
Walleye Capital LLC
Plymouth, MN |
May 14, 2025 Q1 2025 |
198,659
shares
|
$4.15 Million
0.02% of portfolio
|
Q1 2025
New holding
|